// App-Quantinova.ai

: A combination of biomarkers for fibrinolysis and basement membrane destruction predicts mortality in the ECLIPSE COPD cohort

Researchers

Presenter

  • Jannie Sand

Principal Investigators

  • Sarah R Rønnow

  • Lasse Langholm

  • Morten A Karsdal

  • Tina Manon-Jensen

  • Ruth Tal-Singer

  • Bruce E Miller

  • Jørgen Vestbo

  • Diana J Leeming

Medical Centers

  • Nordic Bioscience, Herlev, Denmark

  • GSK R&D, Collegeville, United States of America

  • University of Manchester, Manchester, United Kingdom

Locations

  • Denmark

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT00292552

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved